Coronary disease & ACS

Sex Differences in the Prognostic Value of Circulating Biomarkers in Patients Presenting With Acute Chest Pain

JACC AdvPublished cohort study

Authors' conclusion

In contrast to CRP and GDF-15, increasing concentrations of hs-cTnT, hs-cTnI, and NT-proBNP are associated with higher risk of death and CV events in female than in male patients presenting with suspected NSTE-ACS. Sex-adjustment of hs-cTn and NT-proBNP may increase the accuracy of long-term CV prognostication in women and men.

Study context

Population
Patients admitted with suspected non-ST-segment elevation acute coronary syndrome (NSTE-ACS)patients admitted with suspected NSTE-ACS
Participants
1,476 patients
Exposure
Women vs men
Outcome
Composite of:
  • All-cause mortality
  • Incident myocardial infarction
  • Heart failure hospitalization (per log2 increase of biomarker concentration)
Follow-up
Median 1,547 (IQR: 873-1,842) days

Main finding

As reported in the abstract

GroupHigh-sensitivity cardiac troponin T (hs-cTnT)hs-cTnI
Women1.3, 95% CI: 1.2-1.51.2, 95% CI: 1.1-1.2
Men1.1, 95% CI: 1.0-1.21.0, 95% CI: 1.0-1.1

High-sensitivity cardiac troponin T (hs-cTnT)

Women1.3, 95% CI: 1.2-1.5
Men1.1, 95% CI: 1.0-1.2

hs-cTnI

Women1.2, 95% CI: 1.1-1.2
Men1.0, 95% CI: 1.0-1.1
NT-proBNP: similar interaction with sex
P for interaction = 0.043

Observational data: associations, not effects.

Original publication

Sex Differences in the Prognostic Value of Circulating Biomarkers in Patients Presenting With Acute Chest Pain. JACC Adv. Published 21 January 2025. doi:10.1016/j.jacadv.2024.101567

Summarised from the published abstract; every number is checked against it

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.